Failure to Administer Synthroid Leads to Resident's Hospitalization
Summary
The facility failed to prevent a significant medication error for a resident with a known history of hypothyroidism and myxedema coma. Upon admission, the resident's Synthroid medication, crucial for managing hypothyroidism, was not ordered or administered from the time of admission until the resident's transfer to the hospital several months later. This oversight led to the resident's condition deteriorating significantly, resulting in a transfer to the hospital where the resident was diagnosed with acute toxic metabolic encephalopathy, likely myxedema coma, and an elevated thyroid-stimulating hormone level. The resident's medical records from the previous skilled nursing facility indicated that Synthroid had been prescribed since 2022. However, upon admission to the current facility, the medication order was not transcribed accurately by the nursing staff. The resident's medical history included severe cognitive impairment, hypothyroidism, and previous episodes of myxedema coma, yet these critical details were not adequately addressed in the resident's care plan or medication administration records. Interviews with facility staff revealed a lack of proper communication and verification processes during the resident's admission. The admitting nurse did not accurately transcribe the medication orders, and there was no evidence of the required two-nurse verification process. Additionally, the consultant pharmacist failed to identify the absence of Synthroid in the resident's medication regimen during monthly reviews, further contributing to the oversight.
Removal Plan
- Resident #150 was transferred to the hospital and did not return to the facility. The resident was subsequently discharged to an alternate facility post-hospitalization.
- The facility completed an ADHOC Quality Assurance and Performance Improvement (QAPI) meeting with the Administrator, Physician #825 (medical director), the DON, RN #937 (staff development coordinator), LPN UM #906, Admissions #969, LPN UM #860, Social Service Designee (SSD) #884, Licensed Social Worker (LSW) #820, LPN Minimum Data Set (MDS) #809, Human Resources (HR) #872 to discuss the survey concern and to develop an immediate plan of correction/action that was approved by the Medical Director.
- RN Regional #815 educated the DON and RN #937 on a new Medication Reconciliation Addendum which included two nurse verification at the time of admission, speaking directly with the provider Certified Nurse Practitioner (CNP)/physician via phone (no texting, faxing or picture taking) and included orders that were discontinued (on admission) must be noted in the admission progress notes.
- RN #937 educated 37 of 37 licensed nurses on a new Medication Reconciliation Addendum as well as transcribing physician orders and notifying the physician/CNP when a new admission/readmission entered the facility and verifying medications with two nurses and with the provider as well as entering a progress note reflecting verification of medications and any medications that were discontinued at the time of the verification. All nurses were educated prior to working their next shift.
- RN MDS #982 conducted care plan audits for all residents with diagnoses of hypothyroidism and hyperthyroidism to ensure care plans were addressed for their specific health needs. Care plans were revised and updated as needed.
- LPN UM #860 and LPN UM #906 audited all admissions/readmissions in the last two weeks to verify medications were transcribed correctly and verified with the physician/CNP timely.
- The DON completed chart audits on all residents with a diagnosis of hypothyroidism and all residents receiving Synthroid (Levothyroxine) to ensure the orders were transcribed properly, and the medications was administered as ordered.
- RN Regional #815 completed one-to-one education for the two nurses who admitted Resident #150, LPN #822 and LPN #823, on medication reconciliation to include two nurse verification at the time of admission, speaking with the provider CNP/physician via telephone (no texting, no faxing and no picture taking) and any orders that were discontinued must be noted in the admission progress note.
- Regional RN #815 educated CNP #824 and Physician #825 regarding progress notes and the need for a plan (of care) for diagnosis present in each resident's medical records.
- Regional RN #815 educated Pharmacist #840 on ensuring pharmacy reviews included all diagnoses having an appropriate plan of care in place including medications administered to the residents.
- The facility implemented a plan for the DON/designee to review CNP and physician notes weekly for four weeks to ensure the diagnosis of hypothyroidism has an appropriate plan in place.
- The facility implemented a plan for the DON/designee to review pharmacy recommendations monthly for three months to ensure residents with a diagnosis of hypothyroidism have been reviewed and have an appropriate plan of care in place to address the diagnosis of hypothyroidism.
- The DON/designee would complete daily chart audits, Monday through Sunday for three months on all new admissions/readmissions to ensure the orders were transcribed properly, medications were verified with two nurses and with the provider and the progress note entered in the medical record reflected verification of orders as well as any changes made during the verification progress. The audits would continue until compliance could be maintained for three consecutive months.
- The facility would complete weekly QAPI meetings for four weeks to review all audits regarding this action plan.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release May 27, 2026) and official state health department websites — never guesswork.
Trusted by long-term care providers and associations.



